Literature DB >> 30351060

Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.

Reza Abazari1, Ali Reza Mahjoub1, Farangis Ataei2, Ali Morsali1, Cameron L Carpenter-Warren3, Kayhan Mehdizadeh2, Alexandra M Z Slawin3.   

Abstract

In this work, a bio-metal-organic framework (Bio-MOF) coated with a monodispersed layer of chitosan (CS; CS/Bio-MOF) was synthesized and applied as a pH-responsive and target-selective system for delivery of doxorubicin (DOX) in the treatment of breast cancer. The efficiency of the nanocarrier in loading and releasing DOX was assessed at different pH levels. To monitor the in vitro drug release behavior of the drug-loaded carrier, the carrier was immersed in a phosphate buffered saline solution (PBS, pH 7.4) at 37 °C. According to the observations, the nanocarrier presents a slow and continuous release profile as well as a noticeable drug loading capacity. In addition, the carrier demonstrates a pH-responsive and target-selective behavior by releasing a high amount of DOX at pH 6.8, which is indicative of tumor cells and inflamed tissues and releasing a substantially lower amount of DOX at higher pH values. In addition, the results indicated that pH is effective on DOX uptake by CS/Bio-MOF. A 3.6 mg amount of DOX was loaded into 10 mg of CS/Bio-MOF, resulting in a 21.7% removal at pH 7.4 and 93.0% at pH 6.8. The collapsing and swelling of the CS layers coated on the surface of the Bio-MOFs were found to be responsible for the observed pH dependence of DOX delivery. Moreover, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the trypan blue test were performed on the MCF-7 (breast cancer) cell line in the presence of the CS/Bio-MOF carrier to confirm its biological compatibility. In addition, Annexin V staining was conducted to evaluate the cytotoxicity of the free and loaded DOX molecules. On the basis of the obtained optical microscopy, MTT assay, fluorescence microscopy, and dyeing results, the CS/Bio-MOF carrier greatly enhances cellular uptake of the drug by the MCF-7 cells and, therefore, apoptosis of the cells due to its biocompatibility and pH-responsive behavior.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30351060     DOI: 10.1021/acs.inorgchem.8b01955

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  13 in total

Review 1.  Recent developments on zinc(ii) metal-organic framework nanocarriers for physiological pH-responsive drug delivery.

Authors:  Weicong Liu; Ying Pan; Weiwei Xiao; Hongjia Xu; Dong Liu; Fei Ren; Xinsheng Peng; Jianqiang Liu
Journal:  Medchemcomm       Date:  2019-10-17       Impact factor: 3.597

2.  Catalytic Activity, Stability, and Loading Trends of Alcohol Dehydrogenase Enzyme Encapsulated in a Metal-Organic Framework.

Authors:  Josh Phipps; Hao Chen; Connor Donovan; Dylan Dominguez; Sydney Morgan; Barrett Weidman; Chenguang Fan; M Hassan Beyzavi
Journal:  ACS Appl Mater Interfaces       Date:  2020-06-01       Impact factor: 9.229

3.  Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel.

Authors:  Kayhan Mehdizadeh; Farangis Ataei; Saman Hosseinkhani
Journal:  Med Oncol       Date:  2021-04-27       Impact factor: 3.064

4.  Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies.

Authors:  Negin Mokri; Zahra Sepehri; Farnaz Faninam; Sepideh Khaleghi; Negar Motakef Kazemi; Mehrdad Hashemi
Journal:  Gene Ther       Date:  2021-06-09       Impact factor: 5.250

5.  Zinc Metal-Organic Framework Growing on the Surface of Fruit Peels and Its Photocatalytic Activity.

Authors:  Lu Liu; Liqin Cao; Hongyan Niu; Jide Wang
Journal:  ACS Omega       Date:  2021-04-07

6.  Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.

Authors:  Zahra Gharehdaghi; Rahmatollah Rahimi; Seyed Morteza Naghib; Fatemeh Molaabasi
Journal:  J Biol Inorg Chem       Date:  2021-08-22       Impact factor: 3.358

Review 7.  Recent Advances in Nanoscale Metal-Organic Frameworks Towards Cancer Cell Cytotoxicity: An Overview.

Authors:  Pierre D Harvey; Jessica Plé
Journal:  J Inorg Organomet Polym Mater       Date:  2021-05-12       Impact factor: 3.518

8.  Nanotechnology-based approaches for targeting and delivery of drugs via Hexakis (m-PE) macrocycles.

Authors:  Samaneh Pasban; Heidar Raissi
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

9.  5-FU@DHA-UIO-66-NH2 potentiates chemotherapy sensitivity of breast cancer cells through a microRNA let-7a-dependent mechanism.

Authors:  Jingquan Li; Fanghao Lu; Xin Shao; Bosen You
Journal:  Ann Transl Med       Date:  2021-12

10.  Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug.

Authors:  Meysam Bakhshoudeh; Kayhan Mehdizadeh; Saman Hosseinkhani; Farangis Ataei
Journal:  Med Oncol       Date:  2021-06-28       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.